PATENT CLAIM ANALYSIS

Application Number: 15775810
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-10
Patent Classification: ["514", "547000"]

Abstract:
The present invention provides methods for treating, controlling or mitigating paroxysmal nocturnal hemoglobinuria (PNH), comprising administering a monoacetyldiacylglycerol compound to a patient in need thereof, as well as compositions useful therefor.

Claim (Index 15):
The method of  claim 1  wherein the patient exhibits red or dark discoloration of the urine due to the presence of hemoglobin and hemosiderin from the breakdown of red blood cells, anemia, tiredness, shortness of breath, palpitations, abdominal pain, difficulty swallowing and pain during swallowing, erectile dysfunction, headache, hypertension, pulmonary hypertension, and/or blood clots.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 93.0
- Lexical Diversity: 1.12121
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15775811', '14936464', '14951353', '14912920', '14959750']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7643159238505693
- 35 USC 102 Novelty (BERT): 0.5616996468203991
- Combined Prediction Score: 0.7440542961475524
- Mean Citation Score: 340.9169940000001
- Max Citation Score: 453.0318
- Similarity Product: 292.19011076338285

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test